Literature DB >> 18606770

Human toxocariasis in rural Brazilian Amazonia: seroprevalence, risk factors, and spatial distribution.

Guita Rubinsky-Elefant1, Mônica da Silva-Nunes, Rosely S Malafronte, Pascoal T Muniz, Marcelo U Ferreira.   

Abstract

This population-based cross-sectional study of 403 rural settlers in Brazilian Amazonia revealed an overall rate of IgG seropositivity to Toxocara canis excretory-secretory larval antigen of 26.8% (95% confidence interval [CI], 22.5-31.4%). Multilevel logistic regression analysis identified current infection with hookworm (odds ratio [OR], 2.32; 95% CI, 1.11-4.86) and residence in the most recently occupied sectors of the settlement (OR, 1.81; 95%CI, 1.3-2.52) as significant risk factors for Toxocara seropositivity; age > 14 years (OR, 0.46; 95% CI, 0.28-0.73) and the presence of cats in the household (OR, 0.57; 95% CI, 0.32-1.02) appeared to be protective. Two significant high-prevalence clusters were detected in the area, together comprising 38.9% of the seropositive subjects; households in the clusters had slightly lower socioeconomic status and were less likely to have cats as pets. The obstacles for controlling human toxocariasis in this and other tropical rural settings are discussed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18606770

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  16 in total

1.  Natural infection of free-range chickens with the ascarid nematode Toxocara sp.

Authors:  Danielle R Campos-da-Silva; Jeanne S da Paz; Viviane R Fortunato; Marcus A V Beltrame; Luis C P Valli; Fausto E L Pereira
Journal:  Parasitol Res       Date:  2015-08-29       Impact factor: 2.289

2.  Anti-Toxocara spp. antibodies in an adult healthy population: serosurvey and risk factors in Southeast Brazil.

Authors:  Elaine Cristina Negri; Vamilton Alvares Santarém; Guita Rubinsky-Elefant; Rogério Giuffrida
Journal:  Asian Pac J Trop Biomed       Date:  2013-03

3.  In vitro production of Toxocara canis excretory-secretory (TES) antigen.

Authors:  Divyamol Thomas; N Jeyathilakan; S Abdul Basith; T M A Senthilkumar
Journal:  J Parasit Dis       Date:  2014-12-20

4.  Epidemiology and control of child toxocariasis in the western Brazilian Amazon - a population-based study.

Authors:  Humberto Oliart-Guzmán; Breno M Delfino; Antonio C Martins; Saulo A S Mantovani; Athos M Braña; Thasciany M Pereira; Fernando L C C Branco; Alanderson A Ramalho; Rhanderson G Campos; Pablo S Fontoura; Thiago S de Araujo; Cristieli S M de Oliveira; Pascoal T Muniz; Guita Rubinsky-Elefant; Cláudia T Codeço; Mônica da Silva-Nunes
Journal:  Am J Trop Med Hyg       Date:  2014-02-10       Impact factor: 2.345

5.  Seroprevalence of Larval Toxocarosis in the Czech Republic.

Authors:  Katerina Skulinova; Jan Novak; Martin Kasny; Libuse Kolarova
Journal:  Acta Parasitol       Date:  2019-10-04       Impact factor: 1.440

Review 6.  A Systematic Review of Toxocariasis: A Neglected But High-Prevalence Disease in Brazil.

Authors:  Paula Mayara Matos Fialho; Carlos Roberto Silveira Corrêa
Journal:  Am J Trop Med Hyg       Date:  2016-02-01       Impact factor: 2.345

7.  Seroprevalence of human Toxocara infections in the Roma and non-Roma populations of Eastern Slovakia: a cross-sectional study.

Authors:  D Antolová; P Jarčuška; M Janičko; A Madarasová-Gecková; M Halánová; L Čisláková; Z Kalinová; K Reiterová; M Škutová; D Pella; M Mareková
Journal:  Epidemiol Infect       Date:  2015-01-16       Impact factor: 4.434

8.  A scan statistic for continuous data based on the normal probability model.

Authors:  Martin Kulldorff; Lan Huang; Kevin Konty
Journal:  Int J Health Geogr       Date:  2009-10-20       Impact factor: 3.918

9.  Toxocara canis: molecular basis of immune recognition and evasion.

Authors:  Rick M Maizels
Journal:  Vet Parasitol       Date:  2012-12-20       Impact factor: 2.738

10.  Toxocariasis in waste pickers: a case control seroprevalence study.

Authors:  Cosme Alvarado-Esquivel
Journal:  PLoS One       Date:  2013-01-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.